Riskpilot← Back to searchSign inGet full accessNascorp AB
ABActiveOrg 5592039258Åsbovägen 17General medical practice activities · NACE 8621Est. 20191-4 employees
Revenue 2025
SEK 1,8M
-180218200% vs 2024
EBITDA margin
83.7%
+51425% vs 2024
Equity ratio
49.6%
Financial strength
Net profit 2025
SEK 909K
+31771% vs 2024
| Revenue | SEK 1,8M | -180218200% |
| EBITDA | SEK 1,5M | +51425% |
| Net profit | SEK 909K | +31771% |
| Total assets | SEK 1,9M | +7133% |
| Equity | SEK 935K | +3489% |
| Employees | — | — |
Legal name
Nascorp AB
Org number
5592039258
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 april 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva utveckling av mjukvara och hårdvara, samt därmed förenlig verksamhet. Företagets verksamhet omfattar också datakonsultverksamhet samt värdepappershandel. Aktiebolaget ska även sälja vård- och omsorgstjänst inom hälsa- och sjukvård.
Address
Åsbovägen 17
Email
sndawood@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 30 | 0 | −0 | 1 802 |
| Staff expenses | — | — | −0 | — | −197 |
| EBITDA | −11 | −2 | −1 | −3 | 1 509 |
| Depreciation & amort. | −21 | −21 | — | — | — |
| EBIT | −32 | −23 | −1 | −3 | 1 509 |
| Net financials | — | — | 0 | 0 | 10 |
| Profit before tax | −32 | −23 | −1 | −3 | 1 144 |
| Tax | −0 | −0 | — | — | −235 |
| Net profit | −32 | −23 | −1 | −3 | 909 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 68 | 46 | 29 | 26 | 1 884 |
| Equity | 53 | 30 | 29 | 26 | 935 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 15 | 15 | 0 | — | 574 |
| Total debt | 15 | 15 | — | — | 574 |
EBITDA margin
83.7%
This company
15.8%
Market median
+430% vs market
20212025
Equity ratio
49.6%
This company
38.2%
Market median
+30% vs market
20212025
Return on equity
97.2%
This company
18.4%
Market median
+428% vs market
20212025
Net profit margin
50.4%
This company
8.1%
Market median
+522% vs market
20212025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NDSM Scandinavia AB
Nascorp AB Board members of Nascorp AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dawood Rehman | Deputy Board Member | 0 companies |
| Naveed Ur Rehman | Board of Directors | 0 companies |